FirsthandHealth
medRxiv PreprintsInternational18 November 2026

Statistical analysis plan for the Preventing InfusAte injuries Throughout a Childs Hospitalisation (PATCH) trial: a type 1 hybrid randomised controlled trial

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Up to 20% of hospitalised infants with a peripheral intravenous catheter (PIVC) have an infusate-related injury. The PATCH trial is testing whether an IV biosensor (ivWatch) added to standard observation reduces infiltration and extravasation injuries compared with standard observation alone. Methods: PATCH is a multicentre, type 1 hybrid effectiveness-implementation randomised controlled trial at three Queensland hospitals. Infants under 1 year (weighing at least 1000 g) with a PIVC expected to remain more than 24 hours for intermediate- or high-risk infusates, antimicrobials or c
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.